X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs FDC LTD. - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS FDC LTD. NOVARTIS/
FDC LTD.
 
P/E (TTM) x 421.2 16.0 2,633.6% View Chart
P/BV x 29.7 2.1 1,382.6% View Chart
Dividend Yield % 1.5 0.0 -  

Financials

 NOVARTIS   FDC LTD.
EQUITY SHARE DATA
    NOVARTIS
Mar-18
FDC LTD.
Mar-18
NOVARTIS/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs758319 237.6%   
Low Rs579164 353.0%   
Sales per share (Unadj.) Rs228.461.6 370.5%  
Earnings per share (Unadj.) Rs31.79.9 319.0%  
Cash flow per share (Unadj.) Rs32.812.0 273.8%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs297.173.2 406.1%  
Shares outstanding (eoy) m24.69174.40 14.2%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.93.9 74.7%   
Avg P/E ratio x21.124.3 86.8%  
P/CF ratio (eoy) x20.420.2 101.1%  
Price / Book Value ratio x2.23.3 68.2%  
Dividend payout %31.50-   
Avg Mkt Cap Rs m16,50542,118 39.2%   
No. of employees `0000.75.5 12.1%   
Total wages/salary Rs m1,4452,167 66.7%   
Avg. sales/employee Rs Th8,441.31,943.7 434.3%   
Avg. wages/employee Rs Th2,163.6391.7 552.3%   
Avg. net profit/employee Rs Th1,173.1313.7 373.9%   
INCOME DATA
Net Sales Rs m5,63910,751 52.5%  
Other income Rs m1,718510 337.2%   
Total revenues Rs m7,35711,260 65.3%   
Gross profit Rs m-632,267 -2.8%  
Depreciation Rs m25351 7.2%   
Interest Rs m5514 395.0%   
Profit before tax Rs m1,5752,411 65.3%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m792671 117.9%   
Profit after tax Rs m7841,735 45.2%  
Gross profit margin %-1.121.1 -5.3%  
Effective tax rate %50.327.8 180.5%   
Net profit margin %13.916.1 86.1%  
BALANCE SHEET DATA
Current assets Rs m9,5227,213 132.0%   
Current liabilities Rs m3,2962,104 156.7%   
Net working cap to sales %110.447.5 232.3%  
Current ratio x2.93.4 84.3%  
Inventory Days Days3754 67.2%  
Debtors Days Days2828 102.5%  
Net fixed assets Rs m466,865 0.7%   
Share capital Rs m123175 70.4%   
"Free" reserves Rs m7,21312,586 57.3%   
Net worth Rs m7,33612,761 57.5%   
Long term debt Rs m06 0.0%   
Total assets Rs m11,10515,041 73.8%  
Interest coverage x29.5173.2 17.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.7 71.0%   
Return on assets %7.611.6 65.0%  
Return on equity %10.713.6 78.6%  
Return on capital %22.219.0 117.2%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m611,889 3.2%   
Fx outflow Rs m3,6300-   
Net fx Rs m-3,5701,889 -189.0%   
CASH FLOW
From Operations Rs m1,6101,498 107.4%  
From Investments Rs m687201 341.6%  
From Financial Activity Rs m-2,677-1,694 158.0%  
Net Cashflow Rs m-38010 -3,685.4%  

Share Holding

Indian Promoters % 0.0 68.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 4.7 42.6%  
FIIs % 1.6 7.5 21.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 19.0 113.2%  
Shareholders   41,647 23,730 175.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  ELDER PHARMA  GSK PHARMA  PANACEA BIOTECH  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 305 Points Lower; FMCG and Finance Stocks Witness Huge Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day deep in the red.

Related Views on News

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jul 22, 2019 03:35 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS